Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance

被引：0
|
作者：
Inyoung Lee
Jeremy D. Jokinen
Stephanie Y. Crawford
Gregory S. Calip
Ryan D. Kilpatrick
Todd A. Lee
机构：
[1] University of Illinois at Chicago,Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy
[2] Bristol-Myers Squibb Company,Center for Pharmacoepidemiology and Pharmacoeconomics Research
[3] University of Illinois at Chicago,undefined
[4] Flatiron Health,undefined
[5] Inc.,undefined
[6] AbbVie Inc.,undefined
来源：
Therapeutic Innovation & Regulatory Science | 2021年 / 55卷
关键词：
vigiGrade; Patient support program; Weighting; Completeness; Pharmacovigilance; Well documented;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：142 / 151
页数：9
相关论文
共 50 条
  • [1] Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance
    Lee, Inyoung
    Jokinen, Jeremy D.
    Crawford, Stephanie Y.
    Calip, Gregory S.
    Kilpatrick, Ryan D.
    Lee, Todd A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 142 - 151
  • [2] Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System
    Harpaz, R.
    DuMouchel, W.
    LePendu, P.
    Bauer-Mehren, A.
    Ryan, P.
    Shah, N. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (06) : 539 - 546
  • [3] Completeness of adverse drug reactions reports of the Saudi adverse event reporting system
    Alshammari, Thamir M.
    Al-Kathiri, Wa'ad H.
    Le Louet, Herve
    Aljadhey, Hisham S.
    SAUDI MEDICAL JOURNAL, 2015, 36 (07) : 821 - 828
  • [4] Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance
    Lee, Inyoung
    Lee, Todd A.
    Crawford, Stephanie Y.
    Kilpatrick, Ryan D.
    Calip, Gregory S.
    Jokinen, Jeremy D.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (10) : 1357 - 1366
  • [5] DISPROPORTIONALITY MEASURES USED IN SIGNAL DETECTION: AN ASSESSMENT ON PHARMACOVIGILANCE ADVERSE EVENT REPORTING SYSTEM DATA
    Quattrini, G.
    Zambon, A.
    Simoni, L.
    Fiori, G.
    VALUE IN HEALTH, 2015, 18 (07) : A720 - A720
  • [6] Pharmacovigilance: Three Suggestions for Improving the Quantity and Quality of Adverse Event Reports
    R. A. P. Burt
    Drug information journal : DIJ / Drug Information Association, 2000, 34 : 229 - 238
  • [7] Pharmacovigilance: Three suggestions for improving the quantity and quality of adverse event reports
    Burt, RAP
    DRUG INFORMATION JOURNAL, 2000, 34 (01): : 229 - 238
  • [8] Pharmacovigilance and Nuclear Medicine : French adverse event reports related to Radiopharmaceuticals
    Langlet, S.
    Pascal-Ortiz, D.
    Hillaire-Buys, D.
    Couret, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S735 - S735
  • [9] Signal generation from spontaneous adverse event reports
    Amery, WK
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1999, 8 (02) : 147 - 150
  • [10] Signal Detection Beyond Spontaneous Reports: An Example of Acute Adverse Event Detection in Large Claims Databases
    Guo, Zhenchao
    L'Italien, Gilbert J.
    Mukherjee, Jayanti
    Kawabata, Hugh
    Caminero, Andres Gomez
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S21 - S21
12345